This information was published on 2026-01-21T11:24:25 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2494858 (IR 1819873) |
| (220) |
20 Sep 2024
|
| (300) |
US, 27 Mar 2024, 98471040
|
| (511) (510) |
Class 40
Custom manufacture of pharmaceuticals. Class 42 Pharmaceutical, medical, scientific, and biopharmaceutical research and development; consulting services for others in the field of design, planning, and implementation project management of clinical trials; technical consulting in the field of pharmaceutical studies; consulting services in the field of pharmaceutical research and development; providing on-line non-downloadable software using artificial intelligence, computational methods, and machine learning models for the design and characterization of therapeutic products and drug analysis in the field of drug discovery and development; product development for others in the field of biotechnology and development of pharmaceuticals and therapeutic agents; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations and substances for others; research and development of therapeutics related to the discovery, capture, and analysis of data in the field of drug development; providing scientific laboratory services for the discovery, capture, and analysis of data in the field of drug development. |
| (540) | MIRAI |
| (550) | Word |
| (730) |
MIRAI BIO, INC.
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.